Dana-Farber Cancer Institute shared a post on LinkedIn:

“Congratulations to Dana-Farber’s Ahmed Roman, PhD, who has been honored as a Damon Runyon Cancer Research Foundation 2024 Quantitative Biology Fellow for bringing cutting-edge computational tools to bear on important questions in cancer biology.”

Read further.
Source: Dana-Farber Cancer Institute/LinkedIn

Dana-Farber Cancer Institute, located in Boston, Massachusetts, is a leading institution for cancer treatment and research. It was founded by Sidney Farber on 1947. Currently, the Institute has over 5,000 staff, faculty, and clinicians on board. They manage in excess of 640,000 outpatient visits each year, oversee more than 1,000 hospital discharges annually, and are actively involved in over 1,100 ongoing clinical trials.
As of 2023, Dana-Farber is ranked as the #4 cancer hospital globally. Dana-Farber’s research contributions include the development of Gleevec, a highly successful treatment for chronic myeloid leukemia.